42 related articles for article (PubMed ID: 28545374)
1. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
2. Sfp1 and Rtg3 reciprocally modulate carbon source-conditional stress adaptation in the pathogenic yeast Candida albicans.
Kastora SL; Herrero-de-Dios C; Avelar GM; Munro CA; Brown AJP
Mol Microbiol; 2017 Aug; 105(4):620-636. PubMed ID: 28574606
[TBL] [Abstract][Full Text] [Related]
3. Phosphate is the third nutrient monitored by TOR in
Liu NN; Flanagan PR; Zeng J; Jani NM; Cardenas ME; Moran GP; Köhler JR
Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6346-6351. PubMed ID: 28566496
[TBL] [Abstract][Full Text] [Related]
4. Make azoles active again: chalcones as potent reversal agents of transporters-mediated resistance in Candida albicans.
Nim S; Baghel P; Tran-Nguyen VK; Peres B; Nguyen KA; Pietro AD; Falson P; Prasad R; Boumendjel A
Future Med Chem; 2018 Sep; 10(18):2177-2186. PubMed ID: 30043631
[TBL] [Abstract][Full Text] [Related]
5. Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1.
Gil F; Laiolo J; Bayona-Pacheco B; Cannon RD; Ferreira-Pereira A; Carpinella MC
BMC Complement Med Ther; 2022 Oct; 22(1):264. PubMed ID: 36224581
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new piperazinyl-pyrrolo[1,2-
Guillon J; Nim S; Moreau S; Ronga L; Savrimoutou S; Thivet E; Marchivie M; Di Pietro A; Prasad R; Le Borgne M
RSC Adv; 2020 Jan; 10(5):2915-2931. PubMed ID: 35496110
[TBL] [Abstract][Full Text] [Related]
7. Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against
Chen X; Wu J; Sun L; Nie J; Su S; Sun S
Drug Des Devel Ther; 2021; 15():4701-4711. PubMed ID: 34815665
[TBL] [Abstract][Full Text] [Related]
8. Verapamil inhibits efflux pumps in
Vega-Chacón Y; de Albuquerque MC; Pavarina AC; Goldman GH; Mima EGO
Virulence; 2021 Dec; 12(1):231-243. PubMed ID: 33410730
[TBL] [Abstract][Full Text] [Related]
9. Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5.
Sachs J; Döhl K; Weber A; Bonus M; Ehlers F; Fleischer E; Klinger A; Gohlke H; Pietruszka J; Schmitt L; Teusch N
Front Pharmacol; 2019; 10():400. PubMed ID: 31040786
[TBL] [Abstract][Full Text] [Related]
10. Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism.
Singh S; Fatima Z; Ahmad K; Hameed S
PLoS One; 2018; 13(8):e0203079. PubMed ID: 30157240
[TBL] [Abstract][Full Text] [Related]
11. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
[TBL] [Abstract][Full Text] [Related]
12. Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model.
Mónico A; Nim S; Duarte N; Rawal MK; Prasad R; Di Pietro A; Ferreira MU
Bioorg Med Chem; 2017 Jul; 25(13):3278-3284. PubMed ID: 28479022
[TBL] [Abstract][Full Text] [Related]
13. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.
Tanabe K; Lamping E; Nagi M; Okawada A; Holmes AR; Miyazaki Y; Cannon RD; Monk BC; Niimi M
Mol Microbiol; 2011 Oct; 82(2):416-33. PubMed ID: 21895791
[TBL] [Abstract][Full Text] [Related]
14. Modulators of Candida albicans Membrane Drug Transporters: A Lucrative Portfolio for the Development of Effective Antifungals.
Jaiswal N; Kumar A
Mol Biotechnol; 2024 May; 66(5):960-974. PubMed ID: 38206530
[TBL] [Abstract][Full Text] [Related]
15. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
Prasad R; Rawal MK; Shah AH
Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
[TBL] [Abstract][Full Text] [Related]
16. Modulators of the Efflux Pump Cdr1p of Candida albicans: Mechanisms of Action and Chemical Features.
Tran-Nguyen VK; Prasad R; Falson P; Boumendjel A
Curr Med Chem; 2017; 24(30):3242-3253. PubMed ID: 28545374
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
